Navigation Links
BAETA Corp Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy of Pain Recording Device
Date:5/16/2011

alth improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com/ for more information about our products.

Not a Broker/Dealer or Financial Advisor

Baeta Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in Baeta Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.

No Offer of Securities

None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of Baeta Corp.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presentl
'/>"/>

SOURCE BAETA Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BAETA Corp. Expands Market Awareness Programs
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... its operating results for the second quarter of fiscal ... company will hold a conference call to discuss its ... parties, at 1:30 p.m., Pacific Daylight Time (4:30 p.m., ...
(Date:7/21/2014)... /PRNewswire-iReach/ -- Top Brooklyn Pediatrician Dr. ... article, which suggests that caffeine may be dangerous, according ... A few decades ago parents ... but now it happens rather frequently, according to an ... in the journal Pediatrics, discussed a new study, which ...
(Date:7/21/2014)... 2014 UBM Medica US announces that ... community for primary care clinicians offers a photo collection ... victims of a variety of summer scourges.  ... a host of medical menaces: poison ivy, tick-borne infections, ... the highlights covered on Consultantlive,s topic center that includes ...
Breaking Medicine Technology:Thoratec Schedules Second Quarter Conference Call, Webcast 2Dr. Michael Gabriel a Brooklyn Pediatrician Comments on an Article, Which Suggests Caffeine May Be Dangerous for Children 2ConsultantLive Presents Special Coverage of Summer Scourges 2ConsultantLive Presents Special Coverage of Summer Scourges 3
... 2007 - An alarming study,that appeared in the ... of the American Cancer Society), reports that one-third ... hormonal breast,cancer treatment tamoxifen citrate, discontinue therapy early.(1), ... a major issue that may negatively affect treatment ...
... 2007 - ArQule, Inc.,(NASDAQ: ARQL) today announced that ... for oral presentation the,Company's abstract for ARQ 197 ... a Selective Inhibitor of the c-Met Receptor in ... Annual Meeting, June,1-5, 2007, in Chicago. This presentation ...
Cached Medicine Technology:One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4
(Date:7/22/2014)... Pompano Beach, Florida (PRWEB) July 22, 2014 ... and alcohol treatment center located in Pompano ... of approval from the Joint Commission, an independent ... the United States. Accreditation signifies that the quality ... the Joint Commission standards for safety and performance. ...
(Date:7/22/2014)... Coral, FL (PRWEB) July 22, 2014 ... has opened registration for multiple upcoming real estate investing ... These potentially life-changing events are designed to introduce people ... using in the Canadian market. , A total of ... over a period of three weeks. The goal is ...
(Date:7/22/2014)... 22, 2014 2014 ST. JOHN’S, CONSUMER ... to announce the 2014 Top Service Providers in their ... extend heartfelt congratulations to all this year’s winners; your ... of St. John’s. , Each year across Canada, Consumer ... responses of thousands of consumers and businesses. All winners ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Recently, 2014quinceaneradresses.com, ... has announced its latest assortment of blue and ... promotional prices on these special Quinceanera gowns, hoping to ... before July 30 can get a discounted price, up ... very glad to announce these new items. As one ...
(Date:7/22/2014)... Carolina (PRWEB) July 22, 2014 One woman ... solution managed to lose 20 pounds. Unfortunately, the weight loss ... nauseated for the duration of her time using the pill, ... woman experienced heart flutters and insomnia as a result of ... a heart attack at the age of 37 because of ...
Breaking Medicine News(10 mins):Health News:Florida Drug and Alcohol Addiction Treatment Center Receives Joint Commission Seal of Approval 2Health News:Florida Drug and Alcohol Addiction Treatment Center Receives Joint Commission Seal of Approval 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2Health News:2014 St. John's Consumer Choice Award Winners 2Health News:2014 St. John's Consumer Choice Award Winners 3Health News:2014 St. John's Consumer Choice Award Winners 4Health News:Blue and White Quinceanera Dresses at Low Prices Offered by 2014quinceaneradresses.com 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2
... the best way to fix the broken health care system is a ... from an employment based insurance system. , ... Brookfield, Wisconsin (PRWEB) November ... to fix the broken health care system is a complete overhaul, they ...
... two radio frequency modes into one device. The Accent Dual Mode RF ... on both shallow and deep tissue depths. The technology is the latest ... and Laser Center. , ... New York, NY (PRWEB) November 13, 2008 ...
... 13 TheraQuest Biosciences, Inc. a,development stage ... U.S.,Food and Drug Administration (FDA) has accepted ... its abuse deterrent extended release,strong opioid. TQ-1015 ... deterrent technology., Najib Babul, PharmD, Chief ...
... of members, SEIU officials shut down,California offices ahead ... Caregivers who work in,California hospitals, nursing homes, and ... offices of their national union, the Service,Employees International ... United Healthcare Workers-West (UHW), a,local union that has ...
... helps prevent malaria, ALEPE, Cote d,Ivoire, Nov. ... and their partners worldwide helped Cote d,Ivoire,s,National Program ... health,campaign November 11 that will vaccinate 3.5 million ... the country with bed nets to,stop the spread ...
... 12 Amilpar,(BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and Reuters: AMIL3.SA), ... for the third quarter of 2008., 3rd Quarter ... at the end of September, up 18.2% ... than the previous quarter. -- Adjusted Operating Revenues totaled ...
Cached Medicine News:Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 2Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 3Health News:Accent Dual Mode Skin Tightening Laser is Latest Offering from Juva Skin Center 2Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2Health News:Healthcare Workers Picket Their National Union to Protect Their Voice for Patients 2Health News:Photo: United Methodist Church, Partners Launch Life-Saving Campaign in Cote d'Ivoire 2Health News:Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: